| Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts J Wang, M Jiang, X Chen, LJ Montaner Journal of Leucocyte Biology 108 (1), 17-41, 2020 | 862 | 2020 |
| Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway Y Li, L Gao, X Luo, L Wang, X Gao, W Wang, J Sun, L Dou, J Li, C Xu, ... Blood, The Journal of the American Society of Hematology 121 (3), 499-509, 2013 | 187 | 2013 |
| Low dose decitabine treatment induces CD80 expression in cancer cells and stimulates tumor specific cytotoxic T lymphocyte responses LX Wang, ZY Mei, JH Zhou, YS Yao, YH Li, YH Xu, JX Li, XN Gao, ... PloS one 8 (5), e62924, 2013 | 130 | 2013 |
| Increased PRAME-specific CTL killing of acute myeloid leukemia cells by either a novel histone deacetylase inhibitor chidamide alone or combined treatment with decitabine Y Yao, J Zhou, L Wang, X Gao, Q Ning, M Jiang, J Wang, L Wang, L Yu PloS one 8 (8), e70522, 2013 | 105 | 2013 |
| MiR-410 is overexpressed in liver and colorectal tumors and enhances tumor cell growth by silencing FHL1 via a direct/indirect mechanism Y Wang, J Fu, M Jiang, X Zhang, L Cheng, X Xu, Z Fan, J Zhang, Q Ye, ... PloS one 9 (10), e108708, 2014 | 63 | 2014 |
| A minicircuitry of microRNA‐9‐1 and RUNX1‐RUNX1T1 contributes to leukemogenesis in t (8; 21) acute myeloid leukemia L Fu, J Shi, A Liu, L Zhou, M Jiang, H Fu, K Xu, D Li, A Deng, Q Zhang, ... International Journal of Cancer 140 (3), 653-661, 2017 | 31 | 2017 |
| A novel epigenetic AML1‐ETO/THAP10/miR‐383 mini‐circuitry contributes to t(8;21) leukaemogenesis Y Li, Q Ning, J Shi, Y Chen, M Jiang, L Gao, W Huang, Y Jing, S Huang, ... EMBO Molecular Medicine 9 (7), 933-949, 2017 | 28 | 2017 |
| A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer M Jiang, J Liu, D Yang, D Tross, P Li, F Chen, MM Alam, DL Faustman, ... International immunopharmacology 101, 108345, 2021 | 27 | 2021 |
| AML 1–ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t (8; 21) acute myeloid leukemia L Fu, W Huang, Y Jing, M Jiang, Y Zhao, J Shi, S Huang, X Xue, Q Zhang, ... The FEBS journal 281 (4), 1123-1131, 2014 | 23 | 2014 |
| MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2 M Jiang, Y Yang, L Niu, P Li, Y Chen, P Liao, Y Wang, J Zheng, F Chen, ... Journal for Immunotherapy of Cancer 10 (11), 2022 | 19 | 2022 |
| Inhibition of two-pore channels in antigen-presenting cells promotes the expansion of TNFR2-expressing CD4+Foxp3+ regulatory T cells T He, D Yang, XQ Li, M Jiang, MS Islam, S Chen, Y Chen, Y Yang, ... Science Advances 6 (40), eaba6584, 2020 | 19 | 2020 |
| Rapid detection of AML1 associated fusion genes in patients with adult acute myeloid leukemia and its clinical significance. MM Jiang, L Gao, Y Jing, Y Ding, YY Xu, MH Zhou, C Ma, N Wang, ... Zhongguo shi yan xue ye xue za zhi 21 (4), 821-829, 2013 | 19 | 2013 |
| The RUNX1–ETO fusion protein trans‐activates c‐KIT expression by recruiting histone acetyltransferase P300 on its promoter G Chen, A Liu, Y Xu, L Gao, M Jiang, Y Li, N Lv, L Zhou, L Wang, L Yu, ... The FEBS journal 286 (5), 901-912, 2019 | 16 | 2019 |
| TNFR2 deficiency impairs the growth of mouse colon cancer P Li, Y Yang, X Yang, Y Wang, CK Chou, M Jiang, J Zheng, F Chen, ... International Journal of Biological Sciences 19 (4), 1024, 2023 | 11 | 2023 |
| MiR-495 functions as an adjuvant to radiation therapy by reducing the radiation-induced bystander effect J Fu, M Jiang, M Zhang, J Zhang, Y Wang, S Xiang, X Xu, Q Ye, H Song Acta biochimica et biophysica Sinica 48 (11), 1026-1033, 2016 | 11 | 2016 |
| Epigenetic silencing of eyes absent 4 gene by acute myeloid leukemia 1-eight-twenty-one oncoprotein contributes to leukemogenesis in t (8; 21) acute myeloid leukemia S Huang, MM Jiang, GF Chen, K Qian, HH Gao, W Guan, JL Shi, AQ Liu, ... Chinese medical journal 129 (11), 1355-1362, 2016 | 10 | 2016 |
| TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments P Liao, M Jiang, MS Islam, Y Wang, X Chen Frontiers in Immunology 14, 1097090, 2023 | 7 | 2023 |
| The cancer‑testis antigen NXF2 is activated by the hypomethylating agent decitabine in acute leukemia cells in vitro and in vivo J Zhou, Y Li, Y Yao, L Wang, L Gao, X Gao, X Luo, J Li, M Jiang, M Zhou, ... Molecular Medicine Reports 8 (5), 1549-1555, 2013 | 7 | 2013 |
| Demethylating agent decitabine induces autologous cancer testis antigen specific cytotoxic T lymphocytesin vivo J Zhou, Y Yao, L Wang, W Jia, Y Li, M Jiang, M Zhou, X Gao, R Li, L Wang, ... Chinese Medical Journal 126 (23), 4552-4556, 2013 | 6 | 2013 |
| Therapeutic potential of TNFR2 agonists: a mechanistic perspective Y Chen, M Jiang, X Chen Frontiers in Immunology 14, 1209188, 2023 | 5 | 2023 |